申请人:Hobbs Christopher
公开号:US20100190725A1
公开(公告)日:2010-07-29
Compounds of formula (I) or formula (II) have dopaminergic activity: wherein: R
1
is a carboxyl, carboxyl ester, or carboxamide group; R
2
is a group —C(═O)—NR
3
R
4
, or —S(═O)
2
—NR
3
R
4
; R
3
and R
4
are independently selected from hydrogen, optionally substituted C
1
-C
6
alkyl, (C
1
-C
5
fluoroalkyl)-CH
2
—, -Q, and —CH
2
Q, wherein Q is an optionally substituted monocyclic carbocyclic or heterocyclic ring of (3) to (6) ring atoms; or R
3
and R
4
together with the nitrogen to which they are attached form an optionally substituted monocyclic cycloalkyl or non-aromatic heterocyclic ring of (3) to (8) ring atoms; R
5
is hydrogen, or a natural or non-natural alpha amino acid residue linked via a peptide bond; R
6
is hydrogen or a group R
7
C(═O)—; and R
7
is C
1
-C
6
alkyl, C
1
-C
6
fluoroalkyl or cyclopropyl.
化合物的化学式为(I)或(II),具有多巴胺能活性:其中:R1是羧基,羧酯基或羧酰胺基;R2是基团-C(═O)-NR3R4,或-S(═O)2-NR3R4;R3和R4独立地选择氢,可选取取代的C1-C6烷基,(C1-C5氟代烷基)-CH2-,-Q,和-CH2Q,其中Q是(3)至(6)环原子的可选取取代的单环碳环或杂环;或R3和R4与它们所连接的氮一起形成(3)至(8)环原子的可选取取代的单环环烷基或非芳香族杂环;R5是氢,或通过肽键连接的天然或非天然α-氨基酸残基;R6是氢或基团R7C(═O)-;R7是C1-C6烷基,C1-C6氟代烷基或环丙基。